Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

作者：L. Whilding, Ana C. Parente-Pereira, T. Zabinski, D. Davies, R. Petrovic, Y. Kao, Shobhit Saxena, Alex Romain, Jose A. Costa-Guerra, S. Violette, H. Itamochi, S. Ghaem-Maghami, S. Vallath, J. Marshall, J. Maher · 发表于：Molecular Therapy · 年份：2026 · DOI：10.1016/j.ymthe.2026.06.039 · 被引用次数：39 · 研究领域：Medicine

Citation for published version (APA): Whilding, L. M., Parente Pereira, A. C., Zabinski, T., Davies, D. M., Petrovic, R., Kao, V., Saxena, S. A., Romain, A., Costa-Guerra, J. A., Violette, S., Itamochi, H., Ghaem-Maghami, S., Vallath, S., Marshall, J. F., & Maher, J. (2017). Targeting of aberrant αvβ6 integrin expression in solid tumors using chimeric antigen receptorengineered T-cells. Molecular Therapy, 25(1), 259-273. https://doi.org/10.1016/j.ymthe.2016.10.012